Clarametyx today announced positive topline data from a Phase 1b/2a trial evaluating its novel antibody therapy, CMTX-101, in cystic fibrosis (CF).

New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung repair, and improved lung ...

Among 8- to 9-year-olds, those with vs. without maternal gestational diabetes mellitus exposure had two reduced measures of ...

A recent study published in the journal of Radiology showed that dynamic chest radiography (DCR) may serve as an effective ...

Pulmonary diagnostic tests are a series of tests which evaluate how well the lungs are performing. These tests may be performed to help diagnose disease, monitor disease progression or therapeutic ...

What Is Obstructive Lung Disease? People with obstructive lung disease have shortness of breath because it's hard for them to exhale all the air from their lungs. Because of damage to the lungs or ...

Examining a patient for common or complex pulmonary issues in a primary care setting takes time and expertise — physicians need to ask about symptoms and medical history and determine which tests to ...